Source author record

Ying-Qi Zhao

Ying-Qi Zhao appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Methodology Machine Learning

Catalog footprint

What is connected

4works

2topics

4close collaborators

Actions

Connect this record

Open graph Browse works

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2022arXiv

Handling Nonmonotone Missing Data with Available Complete-Case Missing Value Assumption

Nonmonotone missing data is a common problem in scientific studies. The conventional ignorability and missing-at-random (MAR) conditions are unlikely to hold for nonmonotone missing data and data analysis can be very challenging with few complete data. In this paper, we introduce the available complete-case missing value (ACCMV) assumption for handling nonmonotone and missing-not-at-random (MNAR) problems. Our ACCMV assumption is applicable to data set with a small set of complete observations and we show that the ACCMV assumption leads to nonparametric identification of the distribution for the variables of interest. We further propose an inverse probability weighting estimator, a regression adjustment estimator, and a multiply-robust estimator for estimating a parameter of interest. We studied the underlying asymptotic and efficiency theories of the proposed estimators. We show the validity of our method with simulation studies and further illustrate the applicability of our method by applying it to a diabetes data set from electronic health records.

preprint2022arXiv

Long-term effect estimation when combining clinical trial and observational follow-up datasets

Combining experimental and observational follow-up datasets has received a lot of attention lately. In a time-to-event setting, recent work has used medicare claims to extend the follow-up period for participants in a prostate cancer clinical trial. This allows the estimation of the long-term effect that cannot be estimated by clinical trial data alone. In this paper, we study the estimation of long-term effect when participants in a clinical trial are linked to an observational follow-up dataset with incomplete data. Such data linkages are often incomplete for various reasons. We formulate incomplete linkages as a missing data problem with careful considerations of the relationship between the linkage status and the missing data mechanism. We use the popular Cox proportional hazard model as a working model to define the long-term effect. We propose a conditional linking at random (CLAR) assumption and an inverse probability of linkage weighting (IPLW) partial likelihood estimator. We show that our IPLW partial likelihood estimator is consistent and asymptotically normal. We further extend our approach to incorporate time-dependent covariates. Simulations results confirm the validity of our method, and we further apply our methods to the SWOG study.

preprint2020arXiv

Near-optimal Individualized Treatment Recommendations

Individualized treatment recommendation (ITR) is an important analytic framework for precision medicine. The goal is to assign proper treatments to patients based on their individual characteristics. From the machine learning perspective, the solution to an ITR problem can be formulated as a weighted classification problem to maximize the average benefit that patients receive from the recommended treatments. Several methods have been proposed for ITR in both binary and multicategory treatment setups. In practice, one may prefer a more flexible recommendation with multiple treatment options. This motivates us to develop methods to obtain a set of near-optimal individualized treatment recommendations alternative to each other, called alternative individualized treatment recommendations (A-ITR). We propose two methods to estimate the optimal A-ITR within the outcome weighted learning (OWL) framework. We show the consistency of these methods and obtain an upper bound for the risk between the theoretically optimal recommendation and the estimated one. We also conduct simulation studies, and apply our methods to a real data set for Type 2 diabetic patients with injectable antidiabetic treatments. These numerical studies have shown the usefulness of the proposed A-ITR framework. We develop a R package aitr which can be found at https://github.com/menghaomiao/aitr.

preprint2015arXiv

Active Clinical Trials for Personalized Medicine

Individualized treatment rules (ITRs) tailor treatments according to individual patient characteristics. They can significantly improve patient care and are thus becoming increasingly popular. The data collected during randomized clinical trials are often used to estimate the optimal ITRs. However, these trials are generally expensive to run, and, moreover, they are not designed to efficiently estimate ITRs. In this paper, we propose a cost-effective estimation method from an active learning perspective. In particular, our method recruits only the "most informative" patients (in terms of learning the optimal ITRs) from an ongoing clinical trial. Simulation studies and real-data examples show that our active clinical trial method significantly improves on competing methods. We derive risk bounds and show that they support these observed empirical advantages.